BRIEF published on 01/27/2026 at 06:35, 6 days 1 hour ago Siegfried augmente la capacité de production de substances médicamenteuses aux États-Unis Marché Pharmaceutique Croissance Et Rentabilité Stratégie EVOLVE+ Acquisition De Siegfried Capacités Pharmaceutiques Des États-Unis
BRIEF published on 01/27/2026 at 06:35, 6 days 1 hour ago Siegfried Expands US Drug Substance Capacity Pharmaceutical Market Growth And Profitability EVOLVE+ Strategy Siegfried Acquisition US Drug Capacity
PRESS RELEASE published on 01/27/2026 at 06:30, 6 days 1 hour ago Siegfried to acquire high-quality small molecules drug substance capacity in the US Siegfried, a global CDMO, acquires Noramco Group and Extractas Bioscience for small molecules drug substance capacity in US, strengthening presence and expanding capabilities Acquisition CDMO US Siegfried Small Molecules
BRIEF published on 11/17/2025 at 07:05, 2 months 15 days ago Siegfried AG annonce un changement de directeur financier Industrie Pharmaceutique Transition Du Directeur Financier Siegfried AG Tania Micki Reto Suter
BRIEF published on 11/17/2025 at 07:05, 2 months 15 days ago Siegfried AG Announces CFO Transition Pharmaceutical Industry CFO Transition Siegfried AG Tania Micki Reto Suter
PRESS RELEASE published on 11/17/2025 at 07:00, 2 months 15 days ago Siegfried announces Chief Financial Officer transition Siegfried AG announces Chief Financial Officer transition. Tania Micki to succeed Reto Suter as CFO on July 1, 2026, bringing extensive finance experience Chief Financial Officer Transition Siegfried AG Tania Micki Reto Suter
BRIEF published on 09/29/2025 at 06:35, 4 months 3 days ago DINAMIQS Opens State-of-the-Art cGMP Facility for Viral Vectors Gene Therapy Viral Vectors CGMP Manufacturing SEAL Therapeutics Swiss Biotechnology
BRIEF published on 09/29/2025 at 06:35, 4 months 3 days ago DINAMIQS ouvre une installation cGMP de pointe pour les vecteurs viraux Thérapie Génique Vecteurs Viraux SEAL Therapeutics Fabrication CGMP Biotechnologie Suisse
PRESS RELEASE published on 09/29/2025 at 06:30, 4 months 3 days ago DINAMIQS opens cGMP manufacturing facility for viral vectors DINAMIQS opens cGMP manufacturing facility for viral vectors, marking a significant milestone for Siegfried in cell and gene therapy market expansion Gene Therapy Siegfried DINAMIQS Viral Vectors CGMP Manufacturing
BRIEF published on 09/26/2025 at 06:35, 4 months 6 days ago Change in Siegfried AG's Board Leadership Board Of Directors Leadership Change Siegfried AG Andreas Casutt Beat Walti
Published on 02/02/2026 at 00:05, 7 hours 35 minutes ago Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 2 days 4 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 2 days 6 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 02/02/2026 at 07:32, 7 minutes ago Mister Spex SE Confirms 2025 Guidance – consistent focus on profitability shapes business development
Published on 02/02/2026 at 07:30, 10 minutes ago Carvolix : Résultats du vote de l’Assemblée Générale Mixte du 30 janvier 2026
Published on 02/02/2026 at 07:30, 10 minutes ago Carvolix : Results of the votes of the Combined Shareholders’ General Meeting of January 30, 2026
Published on 02/02/2026 at 07:00, 40 minutes ago Entech signe un contrat avec TotalEnergies pour la construction d’un système de stockage hybride éolien de 8MW/8MWh en Guadeloupe
Published on 01/30/2026 at 18:40, 2 days 13 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 13 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 13 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
